Xoma Seals Botulism Deal, Airs Good Results In Diabetes
This article was originally published in The Pink Sheet Daily
Executive Summary
Antibody cocktail approach spawned for biodefense could be applied to cancer and other diseases.
You may also be interested in...
Troubled Biotechs: Akesis, Metabasis, Xoma, Neurobiological Technologies
California nightmare? San Diego-based Akesis files for Chapter 7 bankruptcy while three other Golden State biotechs try to deal with their own financial maladies.
Troubled Biotechs: Akesis, Metabasis, Xoma, Neurobiological Technologies
California nightmare? San Diego-based Akesis files for Chapter 7 bankruptcy while three other Golden State biotechs try to deal with their own financial maladies.
Xoma Restructures, Focuses On Diabetes Trials
Antibody developer reluctantly releases HCD122 to Novartis for cash now and royalties later.